MetLife, Inc. (MET) Shares Bought by SPF Beheer BV

SPF Beheer BV lifted its stake in MetLife, Inc. (NYSE:MET) by 18.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,334,914 shares of the financial services provider’s stock after acquiring an additional 203,575 shares during the period. MetLife accounts for approximately 2.9% of SPF Beheer BV’s holdings, making the stock its 22nd biggest position. SPF Beheer BV owned approximately 0.13% of MetLife worth $69,349,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Bronfman E.L. Rothschild L.P. lifted its stake in shares of MetLife by 0.7% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 5,505 shares of the financial services provider’s stock worth $302,000 after acquiring an additional 38 shares during the period. Forward Management LLC lifted its stake in MetLife by 0.4% during the second quarter. Forward Management LLC now owns 9,661 shares of the financial services provider’s stock valued at $531,000 after purchasing an additional 41 shares during the last quarter. Aspen Investment Management Inc lifted its stake in MetLife by 0.7% during the second quarter. Aspen Investment Management Inc now owns 7,178 shares of the financial services provider’s stock valued at $394,000 after purchasing an additional 50 shares during the last quarter. Atria Investments LLC lifted its stake in MetLife by 0.4% during the second quarter. Atria Investments LLC now owns 18,986 shares of the financial services provider’s stock valued at $1,043,000 after purchasing an additional 72 shares during the last quarter. Finally, Apriem Advisors lifted its stake in MetLife by 0.6% during the second quarter. Apriem Advisors now owns 13,060 shares of the financial services provider’s stock valued at $718,000 after purchasing an additional 74 shares during the last quarter. 75.85% of the stock is owned by institutional investors.

In other MetLife news, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $54.29, for a total value of $3,024,604.48. Following the completion of the sale, the insider now owns 25,181 shares in the company, valued at approximately $1,367,076.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the completion of the sale, the insider now owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was published by Markets Daily and is the property of of Markets Daily. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.themarketsdaily.com/2017/11/21/metlife-inc-met-shares-bought-by-spf-beheer-bv.html.

Several analysts recently commented on MET shares. J P Morgan Chase & Co started coverage on shares of MetLife in a research note on Monday, July 24th. They set a “hold” rating and a $78.00 target price for the company. BidaskClub lowered shares of MetLife from a “hold” rating to a “sell” rating in a report on Monday, July 24th. TheStreet upgraded shares of MetLife from a “c” rating to a “b-” rating in a report on Monday, July 24th. Keefe, Bruyette & Woods restated a “buy” rating and set a $59.00 price target on shares of MetLife in a report on Thursday, August 3rd. Finally, Wells Fargo & Company restated a “buy” rating on shares of MetLife in a report on Monday, August 7th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $58.40.

Shares of MetLife, Inc. (NYSE MET) traded up $0.32 during trading on Tuesday, hitting $51.97. 3,538,700 shares of the company were exchanged, compared to its average volume of 5,814,891. The firm has a market cap of $54,351.24, a PE ratio of 9.93, a P/E/G ratio of 1.30 and a beta of 1.51. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31. MetLife, Inc. has a 1-year low of $44.26 and a 1-year high of $55.91.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.19. The business had revenue of $16.10 billion during the quarter, compared to analysts’ expectations of $15.47 billion. MetLife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The firm’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the company posted $1.28 EPS. equities analysts predict that MetLife, Inc. will post 4.43 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Investors of record on Monday, November 6th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.08%. The ex-dividend date of this dividend is Friday, November 3rd. MetLife’s dividend payout ratio (DPR) is currently -320.00%.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply